Business Description
Future Medicine Co Ltd
ISIN : KR7341170009
Compare
Compare
Traded in other countries / regions
341170.Korea IPO Date
2022-07-27Description
Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.38 | |||||
| Equity-to-Asset | 0.3 | |||||
| Debt-to-Equity | 1.86 | |||||
| Debt-to-EBITDA | -0.65 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 25.2 | |||||
| 3-Year EPS without NRI Growth Rate | 18.9 | |||||
| 3-Year FCF Growth Rate | 13.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 12.47 | |||||
| 9-Day RSI | 18.3 | |||||
| 14-Day RSI | 22.82 | |||||
| 6-1 Month Momentum % | -11.11 | |||||
| 12-1 Month Momentum % | -71.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.36 | |||||
| Quick Ratio | 1.36 | |||||
| Cash Ratio | 1.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.6 | |||||
| Shareholder Yield % | -52.55 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -396.95 | |||||
| ROA % | -100.01 | |||||
| ROIC % | -140.51 | |||||
| ROC (Joel Greenblatt) % | -715.72 | |||||
| ROCE % | -282.06 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 7 | |||||
| Price-to-Tangible-Book | 8.23 | |||||
| EV-to-EBIT | -2.01 | |||||
| EV-to-EBITDA | -2.17 | |||||
| EV-to-FCF | -2.68 | |||||
| Price-to-Net-Current-Asset-Value | 19.67 | |||||
| Price-to-Net-Cash | 37.02 | |||||
| Earnings Yield (Greenblatt) % | -49.83 | |||||
| FCF Yield % | -34.34 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Future Medicine Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | |||
| EPS (TTM) (â‚©) | -612 | ||
| Beta | 0 | ||
| Volatility % | 68.03 | ||
| 14-Day RSI | 22.82 | ||
| 14-Day ATR (â‚©) | 243.515666 | ||
| 20-Day SMA (â‚©) | 1693.4 | ||
| 12-1 Month Momentum % | -71.22 | ||
| 52-Week Range (â‚©) | 1080 - 8410 | ||
| Shares Outstanding (Mil) | 10.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Future Medicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Future Medicine Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Future Medicine Co Ltd Frequently Asked Questions
What is Future Medicine Co Ltd(XKRX:341170)'s stock price today?
The current price of XKRX:341170 is â‚©1258.00. The 52 week high of XKRX:341170 is â‚©8410.00 and 52 week low is â‚©1080.00.
When is next earnings date of Future Medicine Co Ltd(XKRX:341170)?
The next earnings date of Future Medicine Co Ltd(XKRX:341170) is .
Does Future Medicine Co Ltd(XKRX:341170) pay dividends? If so, how much?
Future Medicine Co Ltd(XKRX:341170) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers